- Hemmo Pharmaceuticals Pvt. Ltd. is India's first & largest manufacturer of synthetic peptides.
- Hemmo Pharmaceuticals is privately held and has been in the business of peptides for the last 38+ years catering to the
Pharmaceuticals, Research and Veterinary industries within India and globally.
- It has been ranked as the leading supplier of bulk Oxytocin to the global market.
- With more than 38 years of experience in synthetic process development and continuous spends in R & D, a well-designed and well equipped plant, multiple international regulatory approvals and the relevant skill sets, Hemmo is set to meet requirements of its customers who are leading International and Indian companies.
- Hemmo has a team of 250+ well trained and highly committed staff including 6 PhDs, 100+ chemistry graduates and postgraduates and 4 engineers.
- In addition to this, Hemmo has a world class manufacturing facility with large manufacturing capacity which has been inspected by US FDA thrice and other regulatory bodies.
- With this infrastructure and a dedicated team in place, Hemmo is able to meet the supply and regulatory needs of its customers worldwide.
Our Key Equipments Are
- Kilo scale reactors for solid and solution phase synthesis
- Multiple Preparative Scale HPLCs systems with columns ranging from 10 cm to 30 cm
- Lyophilisers with tray and manifold assemblies
- WFI loop with State of Art Control
- Microbiology equipments like Autoclave, Incubators & Colony counters.
- HPLCS, polarimeters
- gas chromatography with head space analyzer
- amino acid analyzer
- Liquid chromatography–mass spectrometry (LC-MS)
Approvals & Certifications
- US FDA
- EU GMP
- MFDS - Korea
- WHO GMP
CEP Received From EDQM Authority
- Carbetocin [ EU-DCP and NP ]
- Cetrorelix [ EU-DCP and NP ]
- Desmopressin [ US FDA ]
- Leuprolide [ US FDA ]
- Octreotide [ US FDA ]
- Oxytocin [ US FDA ]
- Vasopressin [ US FDA ]
- Terlipressin [EU-DCP , MFDS and TGA]